Tackling deadly newborn disease, BridgeBio affiliate wins FDA drug approval
February 26, 2021 at 17:55 PM EST
The BridgeBio model is designed to move drugs tackling rare diseases with a well-defined genetic basis quickly and efficiently to approval.
